XML 18 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue    
Total revenue $ 164,957 $ 139,396
Cost of revenue (excluding depreciation and amortization included in selling, general, and administrative, below)    
Cost of revenue 54,575 48,817
Commissions 974 2,056
Marketing 4,628 4,908
Selling, general, and administrative 165,502 49,054
Income (loss) from operations (60,722) 34,561
Other income (expense) net :    
Interest expense (5,091) (1,673)
Gain from change in fair value of warrant liability 5,127  
Gain from change in fair value of earnout liability 61,770  
Loss from extinguishment of debt (445)  
Other income 1,073 17
Total other income (expense), net 62,434 (1,656)
Income before provision for income taxes 1,712 32,905
Income tax expense 388 286
Net income 1,324 32,619
Less: Net income attributable to noncontrolling interest 2,293  
Net income (loss) attributable to biote Corp. stockholders (969)  
Other comprehensive income (loss):    
Foreign currency translation adjustments   (17)
Other comprehensive income (loss) (1) (17)
Comprehensive income $ 1,323 32,602
Net income (loss) per common share    
Basic $ (0.12)  
Diluted $ (0.12)  
Weighted average common shares outstanding    
Basic 8,059,371  
Diluted 8,059,371  
Product Revenue    
Revenue    
Total revenue $ 163,133 137,598
Cost of revenue (excluding depreciation and amortization included in selling, general, and administrative, below)    
Cost of revenue 51,990 46,298
Service Revenue    
Revenue    
Total revenue 1,824 1,798
Cost of revenue (excluding depreciation and amortization included in selling, general, and administrative, below)    
Cost of revenue $ 2,585 $ 2,519